141 related articles for article (PubMed ID: 32196595)
1. ETV4 promotes the progression of gastric cancer through regulating KDM5D.
Cai LS; Chen QX; Fang SY; Lian MQ; Lian MJ; Cai MZ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2442-2451. PubMed ID: 32196595
[TBL] [Abstract][Full Text] [Related]
2. LINC01857 promotes the development of gastric cancer by regulating microRNA-200b.
Chen GR; Sun W; Zheng K; Zhu W
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3648-3656. PubMed ID: 32329840
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
Li Y; Zhou HC; Zhang Y; Huang H
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
[TBL] [Abstract][Full Text] [Related]
4. Increased Mars2 expression upon microRNA-4661-5p-mediated KDM5D downregulation is correlated with malignant degree of gastric cancer cells.
Gu J; Chu K
Cell Biol Int; 2021 Oct; 45(10):2118-2128. PubMed ID: 34273914
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NR027113 promotes malignant progression of gastric carcinoma via EMT signaling pathway.
Chen QF; Hu CF; Sun K; Lang YP
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4746-4755. PubMed ID: 31210301
[TBL] [Abstract][Full Text] [Related]
6. MIIP inhibits malignant progression of hepatocellular carcinoma through regulating AKT.
Fang J; Chen YL; Yao HB; Peng SS; Yang P; Ding ZY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2335-2346. PubMed ID: 32196585
[TBL] [Abstract][Full Text] [Related]
7. HOXA10 promotes the development of bladder cancer through regulating FOSL1.
Cui YP; Xie M; Pan WX; Zhang ZY; Li WF
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2945-2954. PubMed ID: 32271412
[TBL] [Abstract][Full Text] [Related]
8. KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male.
Shen X; Hu K; Cheng G; Xu L; Chen Z; Du P; Zhuang Z
J Cell Biochem; 2019 Aug; 120(8):12247-12258. PubMed ID: 30864186
[TBL] [Abstract][Full Text] [Related]
9. Golgi phosphoprotein-3 (GOLPH3) promote metastasis of nasopharyngeal carcinoma through regulating E-cadherin.
Wang DY; Wang J; Deng D
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8871-8879. PubMed ID: 32964976
[TBL] [Abstract][Full Text] [Related]
10. KIF2A promotes the progression via AKT signaling pathway and is upregulated by transcription factor ETV4 in human gastric cancer.
Zhang X; Wang Y; Liu X; Zhao A; Yang Z; Kong F; Sun L; Yu Y; Jiang L
Biomed Pharmacother; 2020 May; 125():109840. PubMed ID: 32106376
[TBL] [Abstract][Full Text] [Related]
11. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
Tan SF; Ni JX; Xiong H
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-135 inhibits gastric cancer metastasis by targeting SMAD2.
He Y; Wu L; Dai Y; Li J; Liu S
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9436-9444. PubMed ID: 31773690
[TBL] [Abstract][Full Text] [Related]
13. MTMR2 promotes the progression of NK/T cell lymphoma by targeting JAK1.
Wang J; He AL; Zhang WG; Cao XM; Chen YX; Liu J; Zhao WH; Yang Y; Wang JL; Liu HL; Ma XR
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8057-8066. PubMed ID: 32767332
[TBL] [Abstract][Full Text] [Related]
14. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.
Komura K; Jeong SH; Hinohara K; Qu F; Wang X; Hiraki M; Azuma H; Lee GS; Kantoff PW; Sweeney CJ
Proc Natl Acad Sci U S A; 2016 May; 113(22):6259-64. PubMed ID: 27185910
[TBL] [Abstract][Full Text] [Related]
15. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
16. TNFAIP8 regulates cisplatin resistance through TAF-Iα and promotes malignant progression of esophageal cancer.
Zhang DL; Yang N
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4775-4784. PubMed ID: 32432789
[TBL] [Abstract][Full Text] [Related]
17. Circ-DONSON promotes malignant progression of glioma through modulating FOXO3.
Zou Z; Dong YS; Liu JM; Zhao ZH; Li G; Liu DD
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):749-757. PubMed ID: 32016978
[TBL] [Abstract][Full Text] [Related]
18. CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652.
Zhao Y; Hu Y; Shen Q; Chen Q; Zhu XJ; Jiang SS; Zhang Q
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5281-5291. PubMed ID: 32495861
[TBL] [Abstract][Full Text] [Related]
19. STYXL1 promotes malignant progression of hepatocellular carcinoma via downregulating CELF2 through the PI3K/Akt pathway.
Wu JZ; Jiang N; Lin JM; Liu X
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2977-2985. PubMed ID: 32271415
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway.
Dong Y; Wang ZG; Chi TS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1307-1314. PubMed ID: 29565488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]